In a study, it was demonstrated that the SLC3A2-NRG1 fusion gene is involved in lung cancer cell proliferation and tumor growth which is mediated through the generation of ERBB2–ERBB3 heterocomplex and activation of the PI3K/ERK/mTOR signaling pathway. This evidence concerns the gene SLC3A2 and lung cancer.